Introduction
============

Neuroblastoma (NB) is an embryonic tumor derived from sympathetic neural crest cells ([@b1-ol-0-0-11862],[@b2-ol-0-0-11862]). It is the most common type of extracranial solid tumor found in children and the most common type of malignant tumor found in infants and young children, with an incidence rate of 10.5 per million children younger than 14 years old ([@b3-ol-0-0-11862]--[@b5-ol-0-0-11862]). The site of the disease is concealed, and NB easily metastasizes ([@b5-ol-0-0-11862]). Low-risk NB has the characteristics of regression and inducing NB differentiation and maturation *in vitro*, while high-risk NB has high malignancy and can metastasize early ([@b6-ol-0-0-11862]). The prognosis of patients with NB is extremely poor, which accounts for \~12--15% of all pediatric cancer-associated deaths ([@b7-ol-0-0-11862],[@b8-ol-0-0-11862]). In recent years, treatments for low- and medium-risk NB have improved; however, the cure rate for patients with high-risk NB remains low ([@b9-ol-0-0-11862],[@b10-ol-0-0-11862]). It is therefore crucial to develop novel treatments for patients with high-risk NB.

Enhancer of zeste homolog 2 (EZH2) protein is the core catalytic element of polycomb repressor complex 2 (PRC2), which regulates the transcription of target genes via promoting histone H3 methylation ([@b11-ol-0-0-11862]--[@b13-ol-0-0-11862]). Previous studies have demonstrated that high expression level of EZH2 is a poor prognostic factor in various types of cancer ([@b14-ol-0-0-11862],[@b15-ol-0-0-11862]). For example, in pancreatic cancer, EZH2-mediated microRNA-139-5p regulates epithelial-mesenchymal transition and lymph node metastasis ([@b16-ol-0-0-11862]). Moreover, EZH2 and EED directly regulate androgen receptor in advanced prostate cancer ([@b17-ol-0-0-11862]). In NB, EZH2 is highly expressed and can epigenetically silences NB tumor suppressor genes, including CASZ1, CLU, RUNX3 and NGFR, suggesting that EZH2 may be an NB molecular target ([@b18-ol-0-0-11862]).

Long non-coding RNAs (lncRNAs) are a type of RNA of \>200 nucleotides in length that do not encode for proteins. Following their discovery, lncRNAs were considered as 'noises' in the genome transcription process ([@b19-ol-0-0-11862],[@b20-ol-0-0-11862]). However, subsequent studies demonstrated that lncRNAs regulate genes at a number of levels, including epigenetic, genomic transcription and post-transcriptional levels. lncRNAs participate in cancer development and tumorigenesis by affecting tumor cell proliferation, migration, invasion, apoptosis and the cell cycle, and promoting angiogenesis ([@b21-ol-0-0-11862],[@b22-ol-0-0-11862]). lncRNAs directly bind to EZH2, recruiting it to the promoter region of genes to repress their expression levels. lncRNAs also serve as EZH2 effectors or regulators ([@b23-ol-0-0-11862]--[@b25-ol-0-0-11862]). The present study investigated the association between lncRNAs and EZH2 using RNA immunoprecipitation (RIP)-, RNA- and chromatin IP-sequencing (ChIP-seq).

Materials and methods
=====================

### Cell culture

The SH-SY5Y cell line was obtained from the American Type Culture Collection (cat. no. CRL-2266) and the 293T cell line was obtained from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences. Cells were cultured in Dulbecco\'s Modified Eagle Medium supplemented with 10% FBS and 1% penicillin-streptomycin solution (all from Biological Industries) and placed in a humidified incubator with 5% CO~2~ at 37°C. Cell culture dishes were obtained from Hangzhou Xinyou Biotechnology Co., Ltd.

### Construction of short hairpin (sh)RNAs and stable transfected cell lines

EZH2 shRNA plasmids \[designed online ([http//www.sigmaaldrich.com](http//www.sigmaaldrich.com))\] and pLKO1(Genomeditech, Shanghai, China) were selected as vectors. The shRNA target sequences were as follows: Forward shEZH2-F, 5′-CCGGCCCAACATAGATGGACCAAATCTCGAGATTTGGTCCATCTATGTTGGGTTTTTG-3′; reverse shEZH2-R, 5′AATTCAAAAACCCAACATAGATGGACCAAATCTCGAGATTTGGTCCATCTATGTTGGG-3′; forward shControl-F, 5′-CCGGTTCTCCGAACGTGTCACGTCTCGAGACGTGACACGTTCGGAGAATTTTTG-3′; reverse shControl-R, 5′-AATTCAAAAATTCTCCGAACGTGTCACGTCTCGAGACGTGACACGTTCGGAGAA. Lentivirus with shEZH2 was packaged with 293T cells using transfection reagent Lipofectamine^®^ 2000 (Invitrogen; Thermo Fisher Scientific, Inc.). Stably transfected SH-SY5Y cells with shRNA (12 µg) and control (12 µg) were acquired following puromycin selection.

### Western blotting

Cell were lysed using RIPA lysis buffer (Beyotime Institute of Biotechnology) on ice, and western blotting was performed as standard ([@b26-ol-0-0-11862]). Following blocking with 8% skimmed milk for 1 h at room temperature, membranes were incubated with primary antibodies (EZH2; cat. no. 5246S; and β-tubulin; cat. no. 2146S; Cell Signaling Technology, Inc.) on a decolorization shaker at 4°C overnight. After washing with Tris-HCl + 0.05% Tween-20 TBST three times, membranes were incubated with secondary antibody (goat anti-rabbit IgG; 1:2,000; cat. no. CW0107; CoWin Biosciences) for 1 h at room temperature. Protein signals were detected via enhanced chemiluminescence substrate (EMD Millipore).

### RIP-seq

RNA Immunoprecipitation (RIP) was performed followed as Gagliardi *et al* ([@b27-ol-0-0-11862]) In simple terms, RNA was enriched with EZH2 antibody (1:100; cat. no. 5246S; Cell Signaling Technology, Inc) in SH-SY5Y cells. Enriched RNA was broken into short fragments using fragmentation buffer (cat. no. N402-VAHTS; Vazyme Biotech Co., Ltd.) at 94°C for 5 min. Fragmented mRNA was used as a template to synthesize cDNA using random hexamers, buffer, dNTPs and DNA polymerase I (VAHTS Stranded mRNA-seq Library Prep kit for Illumina; cat. no. NR602-01; Vazyme Biotech Co., Ltd.). After the synthesis of the double-stranded cDNA, the double-stranded cDNA was purified. LC magnetic beads were used for purification and target fragment binding. The EP tube was placed on a magnetic stand (beads combined with cDNA), then the supernatant was removed, and washed twice with 80% ethanol for 30 sec each time. End-repair and library preparation was performed by the aforementioned kit (VAHTS Stranded mRNA-seq Library Prep kit for Illumina). Target size selection was performed together with magnetic purification. PCR amplification (using Amplification Mix; cat. no. N611-01; Vazyme Biotech Co., Ltd.) was then performed as following: Initial denaturation 95°C for 3 min, 12 cycles of denaturation at 98°C for 20 sec, annealing at 55°C for 15 sec, elongation at 72°C for 30 sec, and final extension 72°C for 5 min. The primer sequences of PCR were as follows: Forward, 5′AATGATACGGCGACCACCGAGATCTACACACACTCTTTCCCTACACGACGCTCTTCCGATCT-3′; reverse, 5′-CAAGCAGAAGACGGCATACGAGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3′. Agarose electrophoresis was used for quality inspection of the constructed library. Qubit 2.0 (Invitrogen; Thermo Fisher Scientific, Inc.) was used to detect the concentration of the library, and the loading concentration of the library was 42 ng/µl with 20 µl. After library quality tests were passed, libraries were sequenced using an Novaseq 6000 sequencer (Illumina, Inc.) with PE150 model (double-ended 150 bp sequencing) according to effective concentration and target data volume. RIP-seq and subsequent bioinformatics Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was performed by Hangzhou Lianchuan Biotechnology Co., Ltd with the DAVID website (<https://david.ncifcrf.gov/>).

### RNA-seq and analysis

EZH2 protein was knocked down in SH-SY5Y cells using shRNA. Total RNA was obtained from EZH2 knockdown and control groups with TRIzol^®^ (Takara Bio, Inc.). Each group included three replicates. Illumina Paired End Sample Prep kits (Illumina, Inc.) were used to prepare libraries. Each cDNA library was sequenced using an Illumina Hiseq 4000 (cat. no. PE150; Illumina, Inc.). Differential expression levels of lncRNA and mRNA transcripts between the EZH2 knockdown and control groups were measured. RNA-seq and subsequent GO and KEGG analysis was performed by Hangzhou Lianchuan Biotechnology Co., Ltd following the previous study ([@b28-ol-0-0-11862]).

### ChIP-seq

Cells from one 10-cm dish of 80--90% confluence cultures were sonicated 4 times for (30 sec on and 30 sec off) in precooled conditions (Fisher Sonic Dismembrator; Thermo Fisher Scientific, Inc.). DNA was disrupted into fragments of 200--1,000 bp by nucleic acid gel. Anti-EZH2 (1:100; cat. no. 5246S; Cell Signaling Technology, Inc) was used to capture chromatin fragments from cell extracts, and libraries were constructed from immunoprecipitated DNA. An Illumina sequencer was used for high-throughput sequencing of lncRNA and mRNA. ChIP-seq and subsequent GO and KEGG analysis were performed by Hangzhou Lianchuan Biotechnology Co., Ltd. The ChIP protocol was conducted as previously described by Kong *et al* ([@b29-ol-0-0-11862]).

### Differential expression level analysis

Gene expression levels were estimated using fragments per kilobase of transcript per million mapped reads (FPKM) values. Cuffdiff (v2.1.1; <http://cole-trapnell-lab.github.io/cufflinks/>) was used to calculate FPKM values of lncRNAs and mRNAs.DAVID (<https://david.ncifcrf.gov/>) was used to perform GO and KEGG analysis. Official gene symbols of the significantly different genes were enriched. We followed the instructions on the website step by step until acquiring GO and KEGG terms. Significantly differentially expressed genes were obtained using P-value \<0.05.

Results
=======

### RIP-seq identifies EZH2-interacting lncRNAs

*RNA* Immunoprecipitation (RIP) was performed using SH-SY5Y cells and western blotting was used to check IP efficiency ([Fig. 1A](#f1-ol-0-0-11862){ref-type="fig"}). Both IP supernatants and inputs showed bands for the internal reference gene GAPDH, demonstrating protein extraction and the western blotting system is successful. Antibody heavy chain was detected in the IP and IgG lanes, indicating that IP was successful. Distribution statistics for peaks of each functional area of the gene demonstrated that the coding region accounted for 50% and the exon region of a non-coding gene was \~20% ([Fig. 1B](#f1-ol-0-0-11862){ref-type="fig"}). By analyzing the distribution of RPKM values, the gene expression level characteristics of the sample were treated as a whole. If IP was significantly enriched compared with the input group, the total expression level of all genes in the IP group should have been higher than that in the input group ([Fig. 1C](#f1-ol-0-0-11862){ref-type="fig"}). lncRNAs are \>200 nucleotides in length. Length distribution statistics of known lncRNAs were determined. The results demonstrated that lncRNAs 500--1,000 and \>3,500 bp in length were significantly more common than lncRNAs of other lengths in SH-SY5Y cells ([Fig. 1D](#f1-ol-0-0-11862){ref-type="fig"}). A total of 2,595 lncRNAs were identified by counting peaks associated with known lncRNAs. Among these lncRNAs, 94 were identified via exclusion of processed transcripts and retained introns ([Table I](#tI-ol-0-0-11862){ref-type="table"}). GO analysis demonstrated that these lncRNAs were involved in numerous biological processes, including cellular components and molecular functions, such as metabolic process and transcription regulation([Fig. 1E](#f1-ol-0-0-11862){ref-type="fig"}). Furthermore, KEGG analysis indicated that 'Hedgehog signaling pathway' and 'FoxO signaling pathway' were enriched in SH-SY5Y cells. 'Tight junction', 'apoptosis' and 'cell cycle' may also be associated with these lncRNAs ([Fig. 1F](#f1-ol-0-0-11862){ref-type="fig"}).

### RNA-seq for mRNAs and lncRNAs

The results from western blotting demonstrated that EZH2 was significantly downregulated following shRNA transfection ([Fig. 2A](#f2-ol-0-0-11862){ref-type="fig"}). By analyzing the distribution of FPKM values, the gene expression level characteristics of the sample were treated as a whole ([Fig. 2B](#f2-ol-0-0-11862){ref-type="fig"}). Following EZH2 knockdown, 448 up- and 571 downregulated genes were differentially expressed compared with the normal control group ([Fig. 2C and D](#f2-ol-0-0-11862){ref-type="fig"}). A heatmap of the top 100 differentially expressed genes was generated ([Fig. 2E](#f2-ol-0-0-11862){ref-type="fig"}). GO analysis demonstrated that these genes were associated with 'negative regulation of neuron apoptotic processes', 'nervous system development' and 'peripheral nervous system development'. KEGG analysis showed that enriched genes were primarily distributed in the 'TGF-β signaling pathway', 'Hippo signaling pathway' and 'cAMP signaling pathway'. Compared with the normal control group, 32 up- and 35 downregulated lncRNAs were differentially expressed in the shEZH2 group ([Fig. 3A and B](#f3-ol-0-0-11862){ref-type="fig"}; [Table II](#tII-ol-0-0-11862){ref-type="table"}). A heatmap of the top 100 differentially expressed lncRNAs (including known and novel lncRNAs) was generated ([Fig. 3C](#f3-ol-0-0-11862){ref-type="fig"}). GO analysis demonstrated that these lncRNAs were involved in numerous biological processes, including 'regulation of developmental growth', 'peptidyl-tyrosine phosphorylation' and 'histone glutamine methylation' ([Fig. 3D](#f3-ol-0-0-11862){ref-type="fig"}). KEGG analysis demonstrated that 'Hedgehog signaling pathway', 'Parkinson\'s disease' and 'Alzheimer\'s disease' were associated with these lncRNAs ([Fig. 3E](#f3-ol-0-0-11862){ref-type="fig"}).

### ChIP-seq for EZH2

Due to the influence of chromosome conformation, chromosome expression levels in the active region of gene expression levels was more open. This resulted in input DNA reads exhibiting greater abundance in promoter and gene body regions, with a characteristic decrease near the transcription start site (TSS). The distribution of IP DNA is associated with EZH2 proteins, and apparent modifications such as transcription factors and H3K27me3 were enriched in the promoter and gene body regions. Through the distribution of reads in the intervals of these genes, the success of ChIP-seq experiments was verified ([Fig. 4B](#f4-ol-0-0-11862){ref-type="fig"}). Analysis of peak distribution in the genomic functional area indicated that intergenic and promoter-TSS were the most frequent areas ([Fig. 4A](#f4-ol-0-0-11862){ref-type="fig"}). ChIP-seq identified 634 genes located in the promoter region, including 138 long intervening non-coding RNAs (lincRNA; [Table III](#tIII-ol-0-0-11862){ref-type="table"}). GO analysis demonstrated enrichment of 'nervous system development', 'chemical synaptic transmission' and 'trans-synaptic signaling' ([Fig. 4C](#f4-ol-0-0-11862){ref-type="fig"}). KEGG analysis indicated that 'Rap1 signaling pathway', 'cAMP signaling pathway' and 'retrograde endocannabinoid signaling' were enriched ([Fig. 4D](#f4-ol-0-0-11862){ref-type="fig"}).

Discussion
==========

Although numerous treatments for NB currently exist, patients with NB have only 40% survival rate ([@b2-ol-0-0-11862],[@b30-ol-0-0-11862]). A novel treatment is therefore needed to improve survival rate. EZH2 is a member of the polycomb group protein family that is upregulated in various types of cancer, including NB ([@b31-ol-0-0-11862],[@b32-ol-0-0-11862]). Li *et al* ([@b32-ol-0-0-11862]) demonstrated that EZH2 knockdown significantly inhibits NB differentiation. Transcriptome sequencing has demonstrated that neurotrophic receptor tyrosine kinase 1 may be a target of EZH2. Chen *et al* ([@b31-ol-0-0-11862]) reported that the MYCN gene binds to the EZH2 promoter, directly promoting EZH2 expression and EZH2 inhibition of neuronal differentiation in a PRC2-dependent manner ([@b33-ol-0-0-11862]). Tsubota *et al* ([@b34-ol-0-0-11862]) demonstrated that EZH2 inhibitors significantly repress the growth of tyrosine hydroxylase-MYCN NB mice, and that MYCN and PRC2 targets are positively correlated in NB. EZH2 may therefore be considered as a novel target for NB treatment. Bate-Eya *et al* ([@b35-ol-0-0-11862]) demonstrated that high expression of EZH2 has a survival function independent of its methyltransferase activity in NB. Although inhibitors of EZH2 are at pre-clinical stage in many cancers, their efficacy and underlying mechanism in NB remain unknown.

In a previous study, certain lncRNAs were demonstrated to serve key roles in NB. For example, FOXD3-antisense RNA (AS) 1 is downregulated in NB tissues and cell lines; this is an independent prognostic marker for favorable outcomes for patients with NB. FOXD3-AS1 inhibits the progression of NB via repressing poly-ADP ribose polymerase 1-mediated CCCTC-binding factor activation ([@b36-ol-0-0-11862]). The lncRNA pancEts-1 is upregulated and is an independent prognostic factor for unfavorable NB outcomes. In addition, pancEts-1 directly interacts with heterogeneous nuclear ribonucleoprotein K to increase its interaction with β-catenin, resulting in stabilization and transactivation of β-catenin and promotion of the growth and metastasis of NB both *in vitro* and *in vivo* ([@b37-ol-0-0-11862]). EZH2 is a transcriptional repressor associated with lncRNA. Numerous lncRNAs are associated with EZH2 with positive or negative correlation ([@b38-ol-0-0-11862],[@b39-ol-0-0-11862]). Since the interacting gene product enhances the co-expressed gene, positively correlated lncRNA is a potential ligand for EZH2 or has the same transcriptional machinery as EZH2 ([@b40-ol-0-0-11862]). Knocking down EZH2 using small interfering RNA has previously confirmed that lncRNA is negatively correlated with EZH2 expression and is inhibited by EZH2 ([@b41-ol-0-0-11862]). The present study demonstrated that numerous lncRNAs were associated with EZH2. RIP-seq identified 94 lncRNAs that may bind to EZH2 directly. Among lncRNAs, Chi *et al* ([@b42-ol-0-0-11862]) reported that small nucleolar host gene (SNHG) 7 facilitates NB progression via the microRNA (miR)-653-5p/signal transducer and activator of transcription 2 pathway, providing a novel therapeutic target and prognostic biomarker for NB. The lncRNA family with sequence similarity 201A may affect the radiosensitivity of esophageal squamous cell cancer by regulating ataxia telangiectasia mutated (ATM) and mTOR expression via miR-101 ([@b43-ol-0-0-11862]). In the present study, RNA-seq demonstrated that 32 up- and 35 downregulated lncRNAs were differentially expressed in the shEZH2 group compared with the control group. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) ([@b44-ol-0-0-11862]), H19 ([@b45-ol-0-0-11862]) and X-inactive specific transcript (XIST) ([@b46-ol-0-0-11862]) were some of the first reported lncRNAs associated with NB development. Koshimizu *et al* ([@b47-ol-0-0-11862]) demonstrated that expression level of the tumor marker MALAT1 is sensitive to cell surface receptor activation by oxytocin in an NB cell line. In addition, a six-center case-control study identified three single nucleotide polymorphisms (SNPs; rs2839698 G\>A, rs3024270 C\>G and rs217727 G\>A) from the H19 gene in a Chinese population (700 people with NB and 1,516 controls) and investigated the effect of individual and combined SNPs on NB risk ([@b48-ol-0-0-11862]). Zhang *et al* ([@b49-ol-0-0-11862]) demonstrated that XIST downregulates the Dickkopf Wnt signaling pathway inhibitor 1 by promoting H3 histone methylation via EZH2, inhibiting proliferation, migration and invasion of NB cells and limiting tumor development. In addition, SNHG family members, SNHG5, is upregulated while SNHG15 and SNHG16 is downregulated in NB. SNHG16 is reported to facilitate proliferation, migration, invasion and autophagy of NB cells via sponging miR-542-3p and upregulating autophagy-related 5 expression levels ([@b50-ol-0-0-11862]). However, the involvement of these lncRNAs in NB remains unknown. Among the 138 lincRNAs identified by EZH2 ChIP-seq, cancer susceptibility 15 was identified as a tumor suppressor that can regulate numerous genes involved in neural crest development ([@b51-ol-0-0-11862]). GO analysis demonstrated that EZH2 participated in a number of biological processes, such as 'nervous system development', 'regulation of developmental growth' and 'histone glutamine methylation'. KEGG analysis showed that 'Hedgehog signaling pathway' was enriched in both RIP-seq and RNA-seq, indicating that the pathway may be important in EZH2-associated lincRNAs.

In conclusion, the present study demonstrated that numerous lincRNAs could directly bind to EZH2. Certain lincRNAs may regulate or be regulated by EZH2. Certain lncRNAs were associated with N6-methyladenosine and may potentially encode functional polypeptides. In addition, the difficulty of EZH2-targeted drug research may be associated with these lincRNAs. These lincRNAs may provide a novel option for EZH2-centered molecular target therapy.
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![RNA IP-sequencing for lncRNAs binding with EZH2. (A) Western blotting of EZH2 immunoprecipitation. (B) Distribution statistics of peaks in each functional area of gene. NP exon is the exon region of the non-coding gene. (C) All gene RPKM profiles for characteristics of gene expression levels of the sample. (D) Length distribution statistics for known lncRNAs. (E) Gene Ontology and (F) Kyoto Encyclopedia of Genes and Genomes metabolic pathway enrichment analysis of peak-associated genes. Horizontal axis represents significance of enrichment \[-log~10~ (P-value)\], with larger values indicating more significant enrichment. Vertical axis represents enriched terms. Dot size indicates number of differential genes in terms, and dot color indicates the degree of rich factor enrichment. Most significant top 20 terms were selected by sorting by P-value. IP, immunoprecipitation; lncRNA, long non-coding RNA; EZH2, enhancer of zeste homolog 2; UTR, untranslated region; CDS, coding region; NP, no protein.](ol-20-04-11862-g00){#f1-ol-0-0-11862}

![RNA-sequencing for differentially expressed mRNAs. (A) Western blotting of EZH2 knockdown efficiency. (B) Boxplot of FPKM profiles of all genes. (C) Bar and (D) volcano plots and (E) heatmap of differentially expressed genes for shEZH2 vs. shControl. (F) GO and (G) Kyoto Encyclopedia of Genes and Genomes metabolic pathway enrichment analysis of peak-associated genes. EZH2, enhancer of zeste homolog 2; FPKM, fragments per kilobase of transcript per million mapped reads; sh, short hairpin; GO, Gene Ontology.](ol-20-04-11862-g01){#f2-ol-0-0-11862}

![RNA-sequencing for differentially expressed lncRNAs. (A) Bar and (B) volcano plots and (C) heatmap of differentially expressed lncRNAs for shEZH2 vs. shControl. (D) GO and (E) Kyoto Encyclopedia of Genes and Genomes metabolic pathway enrichment analysis of peak-associated genes. lncRNA, long non-coding RNA; sh, short hairpin; EZH2, enhancer of zeste homolog 2; GO, Gene Ontology.](ol-20-04-11862-g02){#f3-ol-0-0-11862}

![ChIP-seq for EZH2. (A) Peak distribution for the genomic functional area of ChIP-seq. (B) Distribution of reads at transcription start site (usually the location of transcription factor binding) for genes. (C) Gene Ontology and (D) Kyoto Encyclopedia of Genes and Genomes metabolic pathway enrichment analysis of peak-associated genes. ChIP-seq, chromatin immunoprecipitation-sequencing; EZH2, enhancer of zeste homolog 2; TSS, transcription start site.](ol-20-04-11862-g03){#f4-ol-0-0-11862}

###### 

lncRNAs determined by RNA immunoprecipitation-sequencing.

  lncRNA name       lncRNA ID         lncRNA type     Chromosome
  ----------------- ----------------- --------------- ------------
  AF001548.2-201    ENST00000574212   antisense_RNA   16
  AC087280.2-201    ENST00000637205   lincRNA         11
  HOXA11-AS-205     ENST00000522863   antisense_RNA   7
  PCBP1-AS1-210     ENST00000416395   antisense_RNA   2
  AP002383.3-201    ENST00000545958   antisense_RNA   11
  CCDC18-AS1-205    ENST00000421202   lincRNA         1
  AL096701.3-202    ENST00000483736   antisense_RNA   22
  AC020661.4-201    ENST00000561388   antisense_RNA   15
  PITRM1-AS1-201    ENST00000430356   antisense_RNA   10
  AL121759.1-201    ENST00000434043   antisense_RNA   20
  AC244517.2-201    ENST00000607216   antisense_RNA   5
  PPP1R26-AS1-202   ENST00000603624   antisense_RNA   9
  AC025188.1-201    ENST00000507514   antisense_RNA   5
  AC092115.3-201    ENST00000575838   antisense_RNA   16
  RAB11B-AS1-201    ENST00000593581   antisense_RNA   19
  AC069503.1-201    ENST00000538710   lincRNA         12
  LINC00843-201     ENST00000429104   lincRNA         10
  AC011477.3-201    ENST00000585571   antisense_RNA   19
  AC010320.4-201    ENST00000594379   antisense_RNA   19
  AL135787.1-201    ENST00000450154   antisense_RNA   9
  AC109587.1-201    ENST00000482368   antisense_RNA   3
  FAM201A-201       ENST00000377680   antisense_RNA   9
  SNHG7-201         ENST00000414282   antisense_RNA   9
  AC138150.1-201    ENST00000589950   antisense_RNA   17
  EMX2OS-206        ENST00000551288   antisense_RNA   10
  AC137932.1-201    ENST00000563087   antisense_RNA   16
  AC005920.2-201    ENST00000509833   antisense_RNA   17
  MZF1-AS1-202      ENST00000600534   antisense_RNA   19
  AC080112.2-201    ENST00000578774   antisense_RNA   17
  AC008741.1-201    ENST00000569456   antisense_RNA   16
  AC024563.1-201    ENST00000601860   antisense_RNA   19
  AC020911.1-201    ENST00000591038   antisense_RNA   19
  AC097467.3-216    ENST00000599555   antisense_RNA   4
  C5orf66-205       ENST00000555438   antisense_RNA   5
  SGO1-AS1-204      ENST00000634618   lincRNA         3
  AC011603.3-201    ENST00000549516   antisense_RNA   12
  ADIRF-AS1-203     ENST00000609111   antisense_RNA   10
  AC106864.1-201    ENST00000510655   antisense_RNA   4
  AC093110.1-202    ENST00000626206   antisense_RNA   2
  MCM3AP-AS1-201    ENST00000414659   antisense_RNA   21
  AC108449.1-202    ENST00000517632   antisense_RNA   8
  AC004923.4-201    ENST00000532296   antisense_RNA   11
  KDM4A-AS1-203     ENST00000434346   antisense_RNA   1
  FO393401.1-201    ENST00000453914   antisense_RNA   20
  AC078777.1-201    ENST00000425371   antisense_RNA   12
  PDZRN3-AS1-201    ENST00000478988   antisense_RNA   3
  AL139423.1-201    ENST00000606802   antisense_RNA   1
  AL118558.1-201    ENST00000557551   antisense_RNA   14
  FOXD1-AS1-201     ENST00000514661   lincRNA         5
  ZFPM2-AS1-207     ENST00000524045   antisense_RNA   8
  AC073167.1-201    ENST00000559303   antisense_RNA   15
  SH3BP5-AS1-202    ENST00000420195   antisense_RNA   3
  AC012170.2-201    ENST00000560380   antisense_RNA   15
  NEXN-AS1-201      ENST00000421331   antisense_RNA   1
  AC092329.1-201    ENST00000594653   lincRNA         19
  DNMBP-AS1-202     ENST00000434409   antisense_RNA   10
  AC013391.1-201    ENST00000560477   antisense_RNA   15
  PKP4-AS1-201      ENST00000342892   antisense_RNA   2
  LINC01089-202     ENST00000429892   lincRNA         12
  AC010978.1-202    ENST00000427050   antisense_RNA   2
  AL606534.3-201    ENST00000437499   antisense_RNA   1
  AL606534.1-201    ENST00000439562   antisense_RNA   1
  AL356599.1-205    ENST00000606388   antisense_RNA   6
  KTN1-AS1-202      ENST00000412224   antisense_RNA   14
  AC004893.2-201    ENST00000360902   antisense_RNA   7
  AC087286.3-201    ENST00000561409   antisense_RNA   15
  AL139021.2-201    ENST00000556390   antisense_RNA   14
  C1orf220-202      ENST00000521244   lincRNA         1
  H1FX-AS1-201      ENST00000383461   antisense_RNA   3
  SEC62-AS1-201     ENST00000479626   antisense_RNA   3
  AL161747.2-201    ENST00000535893   antisense_RNA   14
  DDN-AS1-202       ENST00000547866   antisense_RNA   12
  TTC3-AS1-201      ENST00000424733   antisense_RNA   1
  AC245452.1-201    ENST00000458178   antisense_RNA   22
  AC008676.1-201    ENST00000508443   antisense_RNA   5
  AC022395.1-201    ENST00000451610   antisense_RNA   10
  AC010976.1-203    ENST00000629005   antisense_RNA   2
  AP000229.1-201    ENST00000608591   lincRNA         21
  AC026427.1-201    ENST00000508993   antisense_RNA   5
  AC025043.1-201    ENST00000558047   antisense_RNA   15
  SLC16A1-AS1-204   ENST00000428411   antisense_RNA   1
  ZNF337-AS1-201    ENST00000414393   antisense_RNA   20
  AL451047.1-201    ENST00000424451   antisense_RNA   1
  AC009185.1-201    ENST00000517634   antisense_RNA   5
  AC023790.2-201    ENST00000543321   lincRNA         12
  AC092143.3-201    ENST00000565150   antisense_RNA   16
  ASH1L-AS1-202     ENST00000456633   antisense_RNA   1
  SPG20-AS1-203     ENST00000493739   antisense_RNA   13
  ALKBH3-AS1-201    ENST00000499194   antisense_RNA   11
  SNHG22-201        ENST00000589499   antisense_RNA   18
  AC010624.3-201    ENST00000599914   antisense_RNA   19
  AL592166.1-202    ENST00000428791   antisense_RNA   1

lncRNA, long non-coding RNA; lincRNA, large intergenic noncoding RNA.

###### 

Different lncRNAs determined by RNA-sequencing following enhancer of zeste homolog 2 knockdown.

  lncRNA name   lncRNA ID         Chromosome   Regulation
  ------------- ----------------- ------------ ------------
  MALAT1        ENST00000618132   11           Down
  AL360012.1    ENST00000602813   1            Down
  TTN-AS1       ENST00000629117   2            Down
  AC108488.1    ENST00000422961   2            Up
  EXOC3-AS1     ENST00000623673   5            Down
  AC015813.1    ENST00000582096   17           Up
  AC025171.2    ENST00000515108   5            Down
  DHRS4-AS1     ENST00000555045   14           Down
  AC027237.3    ENST00000558617   15           Down
  SVIL-AS1      ENST00000427063   10           Down
  SNHG15        ENST00000438705   7            Down
  SNHG5         ENST00000431043   6            Up
  AC125494.1    ENST00000396799   12           Down
  AC079781.5    ENST00000641390   7            Down
  LINC00958     ENST00000534477   11           Up
  LRRC75A-AS1   ENST00000472367   17           Down
  H19           ENST00000412788   11           Up
  FAM212B-AS1   ENST00000430373   1            Up
  AC016757.1    ENST00000409942   2            Up
  AL590133.2    ENST00000560481   1            Down
  THAP7-AS1     ENST00000429962   22           Up
  EBLN3P        ENST00000628924   9            Down
  AL139099.5    MSTRG.8510.8      14           Up
  ARF4          MSTRG.21313.4     3            Down
  GRAPL         MSTRG.12628.1     17           Down
  AC006064.4    MSTRG.6110.2      12           Down
  RBFOX2        MSTRG.20343.4     22           Down
  AL139099.5    MSTRG.8510.1      14           Up
  LINC00854     MSTRG.13226.1     17           Up
  AC092329.3    MSTRG.15647.9     19           Down
  FIRRE         MSTRG.30851.6     X            Down
  AL627171.1    MSTRG.8530.1      14           Up
  FAM182B       MSTRG.18928.1     20           Up
  RMRP          MSTRG.29178.1     9            Down
  LINC01021     MSTRG.23474.4     5            Down
  AP002360.2    MSTRG.5480.1      11           Down
  UBC           MSTRG.7623.9      12           Down
  MST1L         MSTRG.421.4       1            Down
  SNHG16        MSTRG.13994.11    17           Down
  CCNG1         MSTRG.24571.8     5            Down
  Z94721.1      MSTRG.26341.2     6            Up
  NDUFA4        MSTRG.26550.2     7            Down
  FBXL16        MSTRG.10641.1     16           Up
  PANK3         MSTRG.24589.2     5            Up
  LINC00854     MSTRG.13226.2     17           Up
  C16orf74      MSTRG.12018.3     16           Up
  MIR34AHG      MSTRG.232.1       1            Up
  MAP2K3        MSTRG.12699.1     17           Up
  ASXL1         MSTRG.18958.4     20           Up
  TJP1          MSTRG.9272.1      15           Down
  MANBAL        MSTRG.19105.1     20           Up
  AL355075.4    MSTRG.8253.2      14           Up
  XIST          MSTRG.30575.16    X            Up
  FIRRE         MSTRG.30851.1     X            Up
  ZNF436-AS1    MSTRG.532.1       1            Up
  RPL37         MSTRG.23579.2     5            Down
  FAM111B       MSTRG.4906.1      11           Up
  AC092821.3    MSTRG.6219.16     12           Up
  NUp210        MSTRG.20805.5     3            Up
  PARG          MSTRG.3414.1      10           Down

lncRNA, long non-coding RNA.

###### 

Promoter of long non-coding RNA determined by chromatin immunoprecipitation-sequencing.

  Gene ID            Chromosome   Start       End         Strand   Annotated_Transcript   logFC         P-value
  ------------------ ------------ ----------- ----------- -------- ---------------------- ------------- -----------------
  RP11-672L10.3      18           907879      908507      −        ENST00000582554        3.129033173   1.33492×10^−12^
  KIRREL3            11           127003233   127004161   −        ENST00000533026        3.003238319   1.50761×10^−06^
  KIRREL3            11           127000973   127001187   −        ENST00000547738        3.003238319   1.50761×10^−06^
  IGF2-AS            11           2139621     2141215     \+       ENST00000381361        2.877117623   1.14607×10^−17^
  AP000282.2         21           33070946    33071173    −        ENST00000454622        2.813201993   4.67603×10^−05^
  RP11-88H9.2        1            111989337   111991186   \+       ENST00000438293        2.775316437   2.86341×10^−10^
  TBX5-AS1           12           114407959   114408321   \+       ENST00000531202        2.734420323   9.25093×10^−07^
  MIR1-1HG           20           62549839    62550053    \+       ENST00000624914        2.522145791   9.65857×10^−10^
  FLJ16779           20           63253277    63253737    \+       ENST00000612722        2.510159699   1.96314×10^−09^
  RP11-92C4.6        9            98942992    98944517    −        ENST00000605631        2.391645807   1.12556×10^−08^
  RP11-672L10.2      18           904551      904765      −        ENST00000582921        2.372166725   1.71009×10^07^
  RP11-672L10.2      18           904176      904390      −        ENST00000582921        2.372166725   1.71009×10^−07^
  RP11-672L10.2      18           906549      907654      −        ENST00000581719        2.372166725   1.71009×10^−07^
  RP3-525N10.2       6            68634166    68635846    −        ENST00000604392        2.366348664   2.47756×10^−10^
  AC099754.1         3            26622451    26622769    −        ENST00000435884        2.28090657    4.94043×10^−05^
  RP11-436F23.1      4            46389763    46390468    \+       ENST00000502455        2.248486391   1.13494×10^−08^
  CTC-235G5.3        5            76084156    76085290    −        ENST00000503652        2.221930293   2.35777×10^−09^
  RP11-274G22.1      X            21373658    21374071    −        ENST00000636317        2.211953324   1.02635×10^−11^
  RP11-343J3.2       10           69574708    69575542    \+       ENST00000428753        2.207584122   1.94744×10^−06^
  AP002856.5         11           131252716   131253002   \+       ENST00000416553        2.203360843   0.001177692
  RP11-452C13.1      7            157867952   157868291   \+       ENST00000608596        2.19401377    0.001695242
  GPR50-AS1          X            151177247   151178372   −        ENST00000454196        2.152759945   3.44626×10^−06^
  LINC00200          10           1159259     1159473     \+       ENST00000425630        2.151520464   0.000313333
  RNF219-AS1         13           77918846    77919422    \+       ENST00000607862        2.145410121   0.000124562
  C8orf34-AS1        8            68331425    68331669    −        ENST00000512294        2.129407806   0.00016937
  RP11-17E2.2        4            21948016    21948230    \+       ENST00000510705        2.129407806   0.00016937
  RP1-269M15.3       20           43189349    43189646    \+       ENST00000611791        2.129407806   0.00016937
  RP6-24A23.3        X            108735146   108736079   \+       ENST00000608811        2.103500759   2.23745×10^−05^
  RP4-683L5.1        11           35418158    35420102    \+       ENST00000534165        2.073937887   6.79163×10^−10^
  PTPRD-AS2          9            10612459    10613283    \+       ENST00000429581        2.04619868    0.000273436
  LINC01210          3            137771274   137772805   \+       ENST00000478772        2.039638671   5.14222×10^−08^
  RP11-563K23.1      7            143363541   143363755   \+       ENST00000609674        2.008614264   1.33265×10^−05^
  RP11-588H7.1       3            14601566    14601780    \+       ENST00000635800        1.989744589   0.00057344
  RP11-343P9.1       8            135456592   135457331   −        ENST00000518674        1.980487281   5.20702×10^−06^
  FGF14-AS1          13           102368126   102368468   \+       ENST00000451630        1.970094904   0.004327089
  CTD-2523D13.2      11           119729856   119730070   \+       ENST00000533253        1.954654555   0.000134587
  RP11-901H12.1      3            21227123    21227337    −        ENST00000634947        1.950333985   0.006647239
  CASC16             16           52606660    52606874    −        ENST00000510238        1.943876617   0.010319298
  ADGRA1-AS1         10           133088588   133089156   −        ENST00000366099        1.898488801   8.76189×10^−06^
  RP11-231C18.1      4            54331878    54332092    \+       ENST00000511634        1.883283382   0.001289255
  MIR519A1           19           53751934    53752148    \+       ENST00000385257        1.874499442   0.025042572
  MIR129-2           11           43580825    43581855    \+       ENST00000362207        1.872185866   1.61125×10^−07^
  CD1E               1            158352934   158353309   \+       ENST00000368167        1.847765953   0.00285251
  RP11-415C15.1      4            27140713    27140939    −        ENST00000506878        1.82461652    0.001888542
  RP11-21C4.1        8            64578103    64578381    −        ENST00000520834        1.797854867   1.29304×10^−05^
  AL022344.7         10           42751909    42752386    −        ENST00000568976        1.796142677   0.000430003
  HAR1B              20           63102600    63103193    −        ENST00000447910        1.784741755   0.000108551
  RP1-273N12.4       6            98832858    98833303    −        ENST00000635423        1.782829544   0.000111871
  RP11-461O7.1       16           56190697    56191236    −        ENST00000501259        1.742859438   0.000158433
  MAPT-AS1           17           45895359    45895627    −        ENST00000579599        1.733234586   9.03861×10^−06^
  RP1-90G24.10       22           32204199    32204413    \+       ENST00000434942        1.705684675   0.000158433
  HAR1A              20           63102059    63102459    \+       ENST00000433161        1.705257532   0.000218753
  LL22NC03-121E8.3   22           48141487    48141701    \+       ENST00000446364        1.699601022   0.004015236
  CTD-2194D22.3      5            1882806     1883957     \+       ENST00000506335        1.67006809    4.45899×10^−07^
  FOXC2-AS1          16           86567608    86568108    −        ENST00000563280        1.667099473   0.000418716
  MIR124-2HG         8            64376996    64377210    \+       ENST00000524060        1.656091826   0.009625718
  RP11-876N24.2      16           10888696    10889194    −        ENST00000572017        1.645368552   0.001847602
  AC010729.1         2            5695877     5696091     \+       ENST00000455579        1.634091046   0.000299766
  RP11-146I2.1       6            15089927    15090141    −        ENST00000437648        1.632781249   0.005823769
  CTD-2089N3.1       5            50967242    50967513    −        ENST00000510349        1.624569379   0.009038249
  RP11-386B13.3      4            185051181   185051395   \+       ENST00000509017        1.614500015   0.009625718
  RP11-1263C18.2     4            576322      576536      \+       ENST00000637674        1.611131906   0.001648005
  RP11-486P11.1      7            20095996    20096210    \+       ENST00000590912        1.608559926   0.014306174
  CTA-125H2.2        22           25898897    25899111    −        ENST00000595102        1.601862196   0.031052599
  CTA-125H2.2        22           25903547    25903761    −        ENST00000608257        1.601862196   0.031052599
  RP11-140A10.3      10           132185784   132186004   −        ENST00000443922        1.597660222   0.000116767
  LHX5-AS1           12           113470956   113471262   \+       ENST00000551357        1.571644358   0.001181247
  RP11-923I11.6      12           51816816    51817177    \+       ENST00000562343        1.562378841   0.0022933
  RP11-255H23.4      19           23875050    23875264    −        ENST00000599944        1.558300834   0.031052599
  RP11-636O21.2      18           39841267    39841481    \+       ENST00000637369        1.546964313   0.013197567
  RP13-977J11.9      12           132168767   132169107   \+       ENST00000619983        1.525547657   0.005463975
  CTA-299D3.8        22           48547918    48548151    −        ENST00000626321        1.50297288    0.045280597
  LINC01497          17           69960846    69961199    \+       ENST00000455460        1.481003517   0.007180229
  FGF12-AS2          3            192514512   192515287   \+       ENST00000443165        1.467946667   0.004402766
  AC145110.1         8            29748261    29748499    \+       ENST00000517491        1.464946227   0.019169253
  DOCK4-AS1          7            111808080   111808294   \+       ENST00000452714        1.464946227   0.019169253
  AC011513.4         19           41786996    41787210    −        ENST00000601409        1.459633143   0.006071182
  RP11-347C12.11     16           30359204    30359692    \+       ENST00000611264        1.442748682   0.002976471
  GRM7-AS1           3            7560233     7560551     −        ENST00000427273        1.438859533   0.015604312
  RP11-164C12.2      15           93423281    93423680    −        ENST00000556708        1.438859533   0.015604312
  RP11-655C2.3       11           58505612    58505826    −        ENST00000527054        1.438859533   0.015604312
  RP11-476M19.2      12           3367415     3367629     \+       ENST00000542449        1.429070956   0.002593418
  RP11-583F24.7      11           18864950    18865166    −        ENST00000524957        1.412555095   0.003778445
  FGF10-AS1          5            44388123    44388744    \+       ENST00000502457        1.397829443   0.000213665
  LINC00342          2            95816770    95817393    −        ENST00000448494        1.39486642    0.011048418
  RP11-31E13.2       10           78696881    78697101    −        ENST00000455498        1.39486642    0.011048418
  CTC-490G23.2       19           43331306    43331853    −        ENST00000595748        1.393500649   0.001691433
  RP11-715J22.3      16           2453190     2453657     −        ENST00000561653        1.382523434   0.009165782
  CTC-293G12.1       5            100658715   100658963   −        ENST00000511592        1.377982806   0.027678904
  RP11-1151B14.2     18           58415921    58416146    \+       ENST00000585470        1.372986331   0.006071182
  LINC00905          19           16034867    16035081    \+       ENST00000589071        1.349005167   0.011418275
  RP11-417J1.1       5            8524277     8524621     \+       ENST00000505784        1.346034828   0.001397979
  RP11-339N8.1       9            108703360   108703574   −        ENST00000415465        1.329449778   0.034844927
  RP11-100E13.1      1            224615665   224615973   −        ENST00000437416        1.313540747   0.003978429
  CTD-2369P2.4       19           10260054    10260664    −        ENST00000587088        1.291980197   0.008432619
  RP11-120A1.1       4            21304232    21304532    \+       ENST00000515680        1.290820753   0.018753813
  CTC-529I10.2       17           16040460    16040674    \+       ENST00000442828        1.289168246   0.019530136
  RP11-404O13.1      1            158147337   158147621   −        ENST00000635685        1.289168246   0.019530136
  RP11-554D14.6      12           107864072   107864415   −        ENST00000547452        1.279468004   0.006918611
  CH17-125A10.2      1            144642430   144642671   −        ENST00000615763        1.278798153   0.017419713
  CH17-125A10.2      1            144643049   144643263   −        ENST00000615763        1.278798153   0.017419713
  RP11-308B16.2      5            12573811    12574025    −        ENST00000502209        1.271835066   0.005263785
  RP5-1159O4.2       7            7553201     7553548     −        ENST00000608770        1.262358355   0.018753813
  SATB1-AS1          3            18444817    18445100    \+       ENST00000414198        1.243227131   0.011232888
  SATB1-AS1          3            18692681    18693359    \+       ENST00000425799        1.243227131   0.011232888
  CTD-2278I10.1      19           17360281    17360495    \+       ENST00000597592        1.242486357   0.048953034
  LINC01252          12           11547257    11547497    \+       ENST00000499291        1.242486357   0.048953034
  LINC01194          5            12574630    12574871    \+       ENST00000505196        1.210837745   0.008262948
  AC002539.1         17           70074000    70074236    −        ENST00000587325        1.203691494   0.02513009
  RP11-30J20.1       8            136529857   136530169   \+       ENST00000524346        1.203691494   0.02513009
  RP11-30J20.1       8            136536567   136536781   \+       ENST00000517345        1.203691494   0.02513009
  RP4-555D20.3       3            43996414    43996646    \+       ENST00000605537        1.192768756   0.014908014
  GFOD1-AS1          6            13486482    13486696    \+       ENST00000446001        1.18462265    0.009134047
  U91319.1           16           13245463    13245712    \+       ENST00000571619        1.165322808   0.03830181
  AC009501.4         2            63048680    63049151    −        ENST00000437346        1.160170784   0.004406531
  AC000403.4         13           76887415    76887795    \+       ENST00000613696        1.151662451   0.003423805
  AC009404.2         2            117833865   117834191   \+       ENST00000420330        1.14253746    0.044449271
  CTD-3224K15.2      5            139649694   139650142   −        ENST00000514287        1.1368449     0.009213888
  RP11-234B24.2      12           4719653     4719867     −        ENST00000527518        1.121955081   0.02513009
  LINC00694          3            44439800    44440014    −        ENST00000636468        1.120622631   0.043957484
  RP1-35C21.1        1            177350670   177350941   \+       ENST00000451341        1.120622631   0.043957484
  RP1-90J20.2        6            2916876     2917111     \+       ENST00000437718        1.106734529   0.017533495
  PABPC5-AS1         X            91435542    91435757    −        ENST00000456187        1.103269093   0.029430716
  MMP25-AS1          16           3059866     3060087     −        ENST00000572574        1.099462156   0.011720469
  RP11-331F9.4       9            35645503    35645717    \+       ENST00000428948        1.070621547   0.038802283
  RP11-307E17.8      9            94331494    94331776    \+       ENST00000454869        1.069513076   0.044449271
  RP11-353N14.1      17           79800162    79800376    \+       ENST00000570512        1.069080411   0.004834217
  RP11-297M9.1       16           9677330     9677544     −        ENST00000561538        1.060801047   0.033509944
  RP11-637O11.2      3            168287466   168287707   \+       ENST00000496247        1.060801047   0.033509944
  RP1-253P7.4        17           17857479    17857693    \+       ENST00000354746        1.060801047   0.033509944
  CTB-118N6.2        5            116573419   116573633   \+       ENST00000508766        1.041943716   0.018538748
  CTD-2516F10.2      11           7435808     7436022     −        ENST00000530846        1.041943716   0.018538748
  CASC15             6            21664562    21664824    \+       ENST00000606336        1.014892605   0.030066952
  RP11-410N8.3       20           32560238    32560452    \+       ENST00000413983        1.008861783   0.030000331
  RP11-805F19.1      18           15165032    15165460    −        ENST00000581690        0.992961131   0.043825627
  RP11-452I5.2       17           74749000    74749350    −        ENST00000585285        0.958163776   0.023648425
  AC009133.12        16           29821695    29821963    −        ENST00000564980        0.896472053   0.046484806
  RP11-680H20.2      11           94237505    94238448    \+       ENST00000506309        0.678965838   0.003627177

[^1]: Contributed equally
